12.07.2015 Views

Ru 486 Misconceptions Myths and Morals - ressourcesfeministes

Ru 486 Misconceptions Myths and Morals - ressourcesfeministes

Ru 486 Misconceptions Myths and Morals - ressourcesfeministes

SHOW MORE
SHOW LESS
  • No tags were found...

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

EndnotesAnother such example is the outcome of prostagl<strong>and</strong>ininteractions with lymphocytes (the white blood cells responsiblefor immune protection) where dosage manipulations permit theinduction of either immunosuppression or immunostimulation.Taken together with the variation in individual sensitivity toprostagl<strong>and</strong>ins, the contradictory effects of both exogenous <strong>and</strong>endogenous prostagl<strong>and</strong>ins are further evidence that RU <strong>486</strong>/PG abortion methods should be resisted.4The type of prostagl<strong>and</strong>in analogue, its dose, administration site<strong>and</strong> infusion time, <strong>and</strong> the number of previous pregnancies, areeach factors which contribute to the abortion-rate in prostagl<strong>and</strong>ininducedterminations.5The guinea pig model was also crucial to the discovery ofsulprostone, which had very little activity in the rat model. I tstherapeutic potential would not have been recognized, but forguinea-pig studies which identified ‘E-prostagl<strong>and</strong>ins to be morepotent abortifacients than F-prostagl<strong>and</strong>ins’ (Elger et al., 1987:79).Subsequent studies in the guinea-pig model indicated the followingascending order of abortifacient activity: PGF 2•, PGE 2, PGE 1,sulprostone/15-methyl-PGF 2•<strong>and</strong> 16,16-dimethyl-PGE 2whichparalleled to a considerable extent the order of effectivenessobserved in human pregnancy.6K.Schmidt-Gollwitzer from Schering Gynecological Therapyreplied to our questions of 22 January 1991 with the followingstatement: ‘We are conducting research on <strong>and</strong> developing antiprogestinsubstances for the treatment of illnesses such as breastcancer or endometriosis. The substances presently underdevelopment are not intended for the indication of abortion’(pers. comm. to LD <strong>and</strong> RK, 19 March 1991).131

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!